| Biomarker ID | 239 |
| PMID | 18061988 |
| Year | 2006 |
| Biomarker | Anterior Gradient 2 Homolog AGR2 |
| Biomarker Basis | Expression Based |
| Biomolecule | Protein |
| Source | Serum |
| Subjects | Humans |
| Regulation | Upregulatated in PCa (3.8 fold) |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Pathways Include:- ERN2 human kinase ARCHS4 coexpression, STYK1 human kinase ARCHS4 coexpression, MAPK15 human kinase ARCHS4 coexpression, TNK1 human kinase ARCHS4 coexpression, CDC42BPG human kinase ARCHS4 coexpression |
| Experiment | Normal Vs Prostate Cancer |
| Type of Biomarker | Diagnostic |
| Cohort | 10 prostate cancer and 10 normal serum samples were used for analysis |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p=0.0021 |
| Method Used | Western Blot |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | AGR2 |